Provided by Tiger Fintech (Singapore) Pte. Ltd.

Novus Therapeutics, Inc.

14.60
0.0000
Volume:- -
Turnover:- -
Market Cap:221.34M
PE:-0.65
High:14.60
Open:14.60
Low:14.60
Close:14.60
Loading ...

Novus Therapeutics Announces Name Change to Eledon Pharmaceuticals; Provides Corporate Update and Outlook

GlobeNewswire
·
04 Jan 2021

We're Not Very Worried About Novus Therapeutics' (NASDAQ:NVUS) Cash Burn Rate

Simply Wall St.
·
29 Dec 2020

Novus Therapeutics Announces Results of Special Meeting of Stockholders

GlobeNewswire
·
22 Dec 2020

BRIEF-Novus Therapeutics Files Prospectus Related To Proposed Resale, Other Disposition Of 12.4 Mln Shares By Selling Stockholders

Reuters
·
12 Dec 2020

Novus Therapeutics Appoints June Lee, M.D., to Board of Directors

Business Wire
·
09 Dec 2020

12 Healthcare Stocks Moving In Wednesday's After-Market Session

Benzinga Staff Writer
·
02 Dec 2020

BRIEF-Novus Therapeutics Reports Q3 2020 Financial Results

Reuters
·
17 Nov 2020

Novus Therapeutics Q3 EPS $(5.51) Down From $(4.01) YoY

Benzinga
·
17 Nov 2020

Novus Therapeutics Reports Third Quarter 2020 Financial Results

Business Wire
·
17 Nov 2020

Novus Therapeutics to Release Third Quarter 2020 Financial Results on Monday, November 16

Business Wire
·
11 Nov 2020

BRIEF-Novus Therapeutics Announces First Patient Enrolled In Phase 2A Clinical Trial Of Anti-Cd40l Antibody At-1501 In Amyotrophic Lateral Sclerosis

Reuters
·
02 Nov 2020

Novus Therapeutics (NVUS) Reports First Patient Enrolled in Phase 2a Clinical Trial of Anti-CD40L Antibody AT-1501 in Amyotrophic Lateral Sclerosis

StreetInsider
·
02 Nov 2020

Novus Therapeutics Announces First Patient Enrolled in Phase 2a Clinical Trial of Anti-CD40L Antibody AT-1501 in Amyotrophic Lateral Sclerosis

Business Wire
·
02 Nov 2020

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:52 PM

Reuters
·
29 Oct 2020

Novus Therapeutics Announces Acquisition of Anelixis Therapeutics

Business Wire
·
15 Sep 2020